Ovarian and Endometrial Endometrioid Carcinoma Following the Use of a Biologic IL-17 Inhibitor

Evidence suggests that IL-17, a pro-inflammatory cytokine, suppresses tumor carcinogenesis; therefore, the use of IL-17 inhibitors accelerates carcinoma growth. We present a case of a perimenopausal female who was diagnosed with synchronous primary ovarian and endometrial endometrioid carcinoma foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Babcock, Luke, Singer, Samantha R, Carbiener, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Obstetrics/Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452048/
https://www.ncbi.nlm.nih.gov/pubmed/37637644
http://dx.doi.org/10.7759/cureus.42481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452048/
https://www.ncbi.nlm.nih.gov/pubmed/37637644
http://dx.doi.org/10.7759/cureus.42481

Ejemplares similares